Eric Mosbrooker - Net Worth and Insider Trading

Eric Mosbrooker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Mosbrooker owns 3 companies in total, including Audentes Therapeutics Inc (BOLD) , Horizon Therapeutics PLC (HZNP) , and Avidity Biosciences Inc (RNA) .

Click here to see the complete history of Eric Mosbrooker’s form 4 insider trades.

Insider Ownership Summary of Eric Mosbrooker

Ticker	Comapny	Transaction Date	Type of Owner
BOLD	Audentes Therapeutics Inc	2020-01-15	SVP & Chief Commercial Officer
HZNP	Horizon Therapeutics PLC	2017-08-23	SVP & Orphan Business Unit
RNA	Avidity Biosciences Inc	2021-08-25	director

Eric Mosbrooker Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Eric Mosbrooker Ownership Network

Ownership Network List of Eric Mosbrooker

No Data

Ownership Network Relation of Eric Mosbrooker

Eric Mosbrooker Owned Company Details

What does Audentes Therapeutics Inc do?

Who are the key executives at Audentes Therapeutics Inc?

Eric Mosbrooker is the SVP & Chief Commercial Officer of Audentes Therapeutics Inc. Other key executives at Audentes Therapeutics Inc include President and COO Natalie C. Holles , SVP & Chief Medical Officer Edward R. Conner , and Executive Vice President & CFO Thomas P Soloway .

Audentes Therapeutics Inc (BOLD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc (BOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc (BOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Audentes Therapeutics Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Audentes Therapeutics Inc Insider Transactions

No Available Data

What does Horizon Therapeutics PLC do?

Who are the key executives at Horizon Therapeutics PLC?

Eric Mosbrooker is the SVP & Orphan Business Unit of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .

Horizon Therapeutics PLC (HZNP) Insider Trades Summary

Over the past 18 months, Eric Mosbrooker made no insider transaction in Horizon Therapeutics PLC (HZNP). Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 40,275 shares made by Jeffrey W Sherman , a net sale of 57,298 shares made by Andy Pasternak , and a net sale of 36,148 shares made by Aaron Cox .

In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,721 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,721 shares.

Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Horizon Therapeutics PLC Insider Transactions

No Available Data

What does Avidity Biosciences Inc do?

Who are the key executives at Avidity Biosciences Inc?

Eric Mosbrooker is the director of Avidity Biosciences Inc. Other key executives at Avidity Biosciences Inc include director & President and CEO Sarah Boyce , Chief Scientific Officer Arthur A Levin , and Chief Financial Officer Michael F Maclean .

Avidity Biosciences Inc (RNA) Insider Trades Summary

Over the past 18 months, Eric Mosbrooker made no insider transaction in Avidity Biosciences Inc (RNA). Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 124,600 shares made by Arthur A Levin , a net sale of 251,092 shares made by Sarah Boyce , and a net sale of 116,616 shares made by Michael F Maclean .

In summary, during the past 3 months, insiders sold 373,641 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 373,641 shares. During the past 18 months, 498,502 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 498,502 shares.

Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avidity Biosciences Inc Insider Transactions

No Available Data

Eric Mosbrooker Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Mosbrooker. You might contact Eric Mosbrooker via mailing address: C/o Horizon Pharma, Plc, Adelaide Chambers, Peter Street, Dublin 8 L2 000000.

Discussions on Eric Mosbrooker

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.